- Services Globally
- Contract Research Organization
Website →
Sapient is an end-to-end biomarker discovery partner for pharmaceutical and biotechnology sponsors. Our platform combines advanced mass spectrometry technologies that assay >11,000 molecules per biosample, computational learning, and an expansive proprietary Human Biology Database of >300,000 individuals to discover circulating biomarkers at unprecedented speed and scale – and make them actionable in optimizing drug pipelines and advancing clinical development.
By identifying biomarkers of biological processes, disease progression, and drug responsiveness, we help elucidate the pathways involved in disease, drug delivery, and the individuals that will respond to a particular intervention, rapidly delivering actionable insights to align patients, disease biology, and specific therapies.
Sapient is CLIA certified.
Sapient is located in San Diego, CA (USA) and services customers globally.
Contact Us
Trajan Scientific Americas Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of blood. They are CE-IVD in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada and Ukraine.
In the USA, Mitra devices are supplied as a Research-Use Only (RUO) product, to assist in method development, other research-related and non-diagnostic activities. Mitra has not been validated for use with any diagnostic testing. The suitability of Mitra for any analytical application must be evaluated and validated by the laboratory or research institute in a manner consistent with local regulatory requirements.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use.
Mitra®, VAMS® & hemaPEN® are registered trademarks owned by entities in the Trajan Group.
Copyright © 2022. All rights reserved.
